Today

Agents

Chat

Arena

Discover

More

App

Bone Biologics to participate in H.C. Wainwright Global Investment Conference - BBLG News | Rallies

Bone Biologics to participate in H.C. Wainwright Global Investment Conference

BBLG•2026-09-03

Conference participation scheduled for September

Bone Biologics will participate in the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-16, 2026.
CEO Jeff Frelick is scheduled to hold one-on-one investor meetings during the Sept. 14-16 conference window.

Related News

US weekly jobless claims rise marginally amid stable labor market

SPY•2026-09-03

Aptevo Therapeutics reports early data for blood cancer therapy; shares fall

APVO•2026-09-03

Fed's Waller signals willingness to be patient to watch for disinflation

•

2026-09-03

S&P 500, Nasdaq eye tepid open as Middle East tensions weigh

SPY•2026-09-03

CarGurus names Matthew Mandel chief financial officer, effective Oct. 19

CARG•2026-09-03